Short Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Increases By 22.4%

VanEck Pharmaceutical ETF (NASDAQ:PPH) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 1,420,000 shares, an increase of 22.4% from the May 15th total of 1,160,000 shares. Based on an average daily volume of 149,400 shares, the short-interest ratio is presently 9.5 days.

Institutional Trading of VanEck Pharmaceutical ETF

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC grew its position in VanEck Pharmaceutical ETF by 2.6% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 7,296 shares of the company’s stock valued at $594,000 after buying an additional 185 shares during the period. Aspiriant LLC increased its stake in shares of VanEck Pharmaceutical ETF by 5.6% in the 1st quarter. Aspiriant LLC now owns 6,000 shares of the company’s stock valued at $544,000 after purchasing an additional 320 shares in the last quarter. Allworth Financial LP purchased a new position in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at about $28,000. Global Retirement Partners LLC boosted its position in VanEck Pharmaceutical ETF by 2,343.8% during the first quarter. Global Retirement Partners LLC now owns 391 shares of the company’s stock worth $35,000 after purchasing an additional 375 shares in the last quarter. Finally, Comerica Bank grew its holdings in VanEck Pharmaceutical ETF by 39.4% in the first quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after purchasing an additional 378 shares during the period.

VanEck Pharmaceutical ETF Price Performance

NASDAQ PPH opened at $91.34 on Monday. VanEck Pharmaceutical ETF has a 1 year low of $74.05 and a 1 year high of $92.97. The company has a market capitalization of $542.56 million, a PE ratio of 21.04 and a beta of 0.72. The company has a fifty day moving average of $88.83 and a 200 day moving average of $86.79.

VanEck Pharmaceutical ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were issued a $0.5328 dividend. The ex-dividend date of this dividend was Monday, April 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.